ACE and heart failure: It is a major cause of morbidity and mortality, and its management requires effective and evidence-based treatment strategies.[1,2] Among the pharmacological options, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are commonly prescribed for heart failure patients to reduce symptoms, improve quality of life, and decrease mortality.